Search Results for: coronavirus

  • About 1013 Results
  • Page 7 of 51
This photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. (Pfizer)

US gives final clearance to COVID-19 shots for kids 5 to 11

By Lauran Neergaard and Mike Stobbe AP Medical Writers U.S. health officials on Tuesday gave the final signoff to Pfizer’s kid-size COVID-19 shot, a milestone… Continue reading

This photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. (Pfizer)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Monday, Nov.1

The latest local and state numbers.

  • Nov 1, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
This October 2021 photo provided by Pfizer shows boxes of kid-size doses of its COVID-19 vaccine. The U.S. moved a step closer to expanding vaccinations for millions more children as a panel of government advisers on Tuesday, Oct. 26, endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. (Pfizer via AP)

City plans five pediatric vaccine clinic for next week

Sign ups to come.

This October 2021 photo provided by Pfizer shows boxes of kid-size doses of its COVID-19 vaccine. The U.S. moved a step closer to expanding vaccinations for millions more children as a panel of government advisers on Tuesday, Oct. 26, endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. (Pfizer via AP)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Friday, Oct. 29

The latest local and state numbers.

  • Oct 29, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
The Biden administration previously announced it would require employees of certain contractors and large employers to be vaccinated against COVID-19. On Friday, Gov. Mike Dunleavy and Attorney General Treg Taylor announced the state is joining a lawsuit over the announced mandate. (Ben Hohenstatt / Juneau Empire file)

Alaska joins lawsuit over federal vaccine mandate

Smallpox precedents.

The Biden administration previously announced it would require employees of certain contractors and large employers to be vaccinated against COVID-19. On Friday, Gov. Mike Dunleavy and Attorney General Treg Taylor announced the state is joining a lawsuit over the announced mandate. (Ben Hohenstatt / Juneau Empire file)
This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. On Friday, Oct. 29, 2021, the Food and Drug Administration paved the way for children ages 5 to 11 to get Pfizer's COVID-19 vaccine. One more regulatory hurdle remains, as advisers to the Centers for Disease Control and Prevention will make more detailed recommendations on which youngsters should get vaccinated, with a final decision by the agency’s director expected shortly afterward. (Pfizer)

FDA paves way for Pfizer COVID-19 vaccinations in young kids

The FDA cleared kid-size doses for emergency use.

This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. On Friday, Oct. 29, 2021, the Food and Drug Administration paved the way for children ages 5 to 11 to get Pfizer's COVID-19 vaccine. One more regulatory hurdle remains, as advisers to the Centers for Disease Control and Prevention will make more detailed recommendations on which youngsters should get vaccinated, with a final decision by the agency’s director expected shortly afterward. (Pfizer)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Thursday, Oct. 28

The latest local and state numbers.

  • Oct 28, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Wednesday, Oct. 28

The latest local and state numbers.

  • Oct 27, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
(Michael S. Lockett / Juneau Empire)

Opinion: Future cruise seasons depend on assured public and environmental health

By Verner Wilson III and Varsha Mathrani Earlier this year, the United States Senate passed the Alaska Tourism Recovery Act, sponsored by Sens. Lisa Murkowski… Continue reading

  • Oct 27, 2021
  • By Verner Wilson III and Varsha Mathrani
(Michael S. Lockett / Juneau Empire)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Tuesday, Oct. 26

The latest local and state numbers.

  • Oct 26, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Monday, Oct. 25

The latest local and state numbers.

  • Oct 25, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
(Peter Segall / Juneau Empire File)

Opinion: Walker poised better for success than Dunleavy

A thorough assessment of the fitness for duty of Govs. Bill Walker and Mike Dunleavy shows Walker is vastly more able and likely to succeed… Continue reading

  • Oct 25, 2021
(Peter Segall / Juneau Empire File)
Students board a school bus on New York’s Upper West Side. Even as most students return to learning in the classroom this school year, disruptions to in-person learning, from missing one day because of a late school bus to an entire two weeks at home due to quarantine, remain inevitable as families and educators navigate the ongoing pandemic. (AP Photo / Richard Drew)

Disruptions to schooling fall hardest on vulnerable students

Many families don’t know where to turn for information, or sometimes can’t be reached.

Students board a school bus on New York’s Upper West Side. Even as most students return to learning in the classroom this school year, disruptions to in-person learning, from missing one day because of a late school bus to an entire two weeks at home due to quarantine, remain inevitable as families and educators navigate the ongoing pandemic. (AP Photo / Richard Drew)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Friday, Oct. 22

The latest local and state numbers.

  • Oct 22, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML

COVID at a glance for Wednesday, Oct. 20

The most recent state and local figures

This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML
This screen capture from surveillance footage released by the Anchorage Police Department shows a masked man vandalizing the Alaska Jewish Museum in Anchorage in May. (Courtesy photo / APD)

Museums statewide condemn antisemitic vandalism

Two incidents, one in May, one in September, have marred the museum this year.

This screen capture from surveillance footage released by the Anchorage Police Department shows a masked man vandalizing the Alaska Jewish Museum in Anchorage in May. (Courtesy photo / APD)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML

COVID at a glance for Tuesday, Oct. 19

The most recent state and local figures

This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML
This October 2020 file photo shows the University of Alaska Southeast Campus, which doesn’t currently have a broad COVID-19 vaccine mandate but UA President Pat Pitney said Monday one would have to come eventually. (Peter Segall / Juneau Empire file)

UA president: No systemwide mandate for now, but vaccine requirement coming

It’s coming.

This October 2020 file photo shows the University of Alaska Southeast Campus, which doesn’t currently have a broad COVID-19 vaccine mandate but UA President Pat Pitney said Monday one would have to come eventually. (Peter Segall / Juneau Empire file)
Teaser

Then Now: Looking back on pandemic response

Comparing messaging from 1918 to 2021

Teaser
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML

COVID at a glance for Thursday, Oct. 14

The most recent state and local figures

This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML